Danaher Corporation (DHR)
NYSE · Healthcare · Diagnostics & Research
Danaher Corporation is a Healthcare company with a market capitalization of $138.86B, a trailing P/E ratio of 38.0, and a dividend yield of 0.71%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 21, 2026 | $2.06 | $1.94 | +6.2% |
| Q4 2025 | January 28, 2026 | $2.23 | $2.19 | +1.8% |
| Q3 2025 | October 21, 2025 | $1.89 | $1.72 | +9.9% |
| Q2 2025 | July 22, 2025 | $1.80 | $1.64 | +9.8% |
| Q1 2025 | April 22, 2025 | $1.88 | $1.64 | +14.6% |
| Q4 2024 | January 29, 2025 | $2.14 | $2.16 | -0.9% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Danaher Corporation's market cap?
As of June 29, 2026, Danaher Corporation (DHR) has a market capitalization of $138.86B.
What is Danaher Corporation's P/E ratio?
Danaher Corporation trades at a trailing price-to-earnings (P/E) ratio of 38.0. Its forward P/E is 23.2.
Does Danaher Corporation pay a dividend?
Yes — Danaher Corporation pays a dividend yielding 0.71%, an annual payout of $1.36 per share.
What sector is DHR in?
Danaher Corporation is in the Healthcare sector, specifically the Diagnostics & Research industry.
What was Danaher Corporation's revenue?
In its latest reported fiscal year (ending December 31, 2025), Danaher Corporation reported revenue of $24.57B and net income of $3.61B.
Ask your own questions about DHR
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.